The ALS ‐associated E425K mutation uncouples DNAJC7 from the Hsp70 chaperone cycle
The FEBS Journal · 2026
DOI: 10.1111/febs.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Bar Elmaleh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: HSP70 Heat-Shock Proteins, Amyotrophic Lateral Sclerosis, HSP40 Heat-Shock Proteins, Mutation. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israel Science Foundation, Minerva Foundation, H2020 European Research Council.
Abstract (Originalsprache)
DNAJC7, a member of the J‐domain protein (JDP/Hsp40) family, plays a key role in protein homeostasis by regulating Hsp70 activity and preventing protein aggregation. Mutations in DNAJC7 have been linked to amyotrophic lateral sclerosis (ALS); yet, the molecular mechanisms by which these variants impair chaperone function remain poorly understood. DNAJC7 is a conserved chaperone featuring both a canonical J‐domain, essential for Hsp70 activation, and three TPR domains, which serve as protein–protein binding interfaces. Here, we investigate the structural and functional consequences of the ALS‐associated E425K mutation located within the conserved J‐domain. Using NMR spectroscopy, we show that although the E425K mutation does not alter the structure of the protein, it significantly disrupts the conserved J‐domain–Hsp70 interaction. We further identify a second Hsp70‐binding interface within the TPR domains, which interacts with the C‐terminal EEVD motif of Hsp70. This TPR–EEVD interaction is preserved in the E425K mutant but cannot compensate for the loss of J‐domain binding or restore DNAJC7‐dependent Hsp70 activation. Functionally, we show that the TPR domains of DNAJC7 directly bind TDP‐43 and prevent its aggregation and that this holdase activity is retained in the E425K mutant. However, the mutant fails to support client transfer to Hsp70 and the subsequent Hsp70‐mediated substrate refolding. Together, these findings demonstrate that DNAJC7 requires coordinated action of both J‐domain and TPRs to regulate Hsp70 function and that disruption of J‐domain‐mediated activation uncouples DNAJC7 from the Hsp70 cycle, providing a mechanistic basis for its dysfunction in ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
ORCID-Profile: Rina Rosenzweig
Förderung
- Israel Science Foundation
- Minerva Foundation
- H2020 European Research Council
Zitieren
APA
Elmaleh, B., Faust, O., & Rosenzweig, R. (2026). The ALS ‐associated E425K mutation uncouples DNAJC7 from the Hsp70 chaperone cycle. The FEBS Journal. https://doi.org/10.1111/febs.70395
Vancouver
Elmaleh B, Faust O, Rosenzweig R. The ALS ‐associated E425K mutation uncouples DNAJC7 from the Hsp70 chaperone cycle. The FEBS Journal. 2026. doi:10.1111/febs.70395
BibTeX
@article{Elmaleh2026,
author = {Elmaleh, Bar and Faust, Ofrah and Rosenzweig, Rina},
title = {The ALS ‐associated E425K mutation uncouples DNAJC7 from the Hsp70 chaperone cycle},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70395}
}
EUVIMED